share_log

Unveiling 8 Analyst Insights On Corcept Therapeutics

コーセプトセラピューティックスに関する8つのアナリストの見解を発表

Benzinga ·  07/30 08:00

Corcept Therapeutics (NASDAQ:CORT) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings62000
Last 30D11000
1M Ago01000
2M Ago20000
3M Ago30000

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $46.5, along with a high estimate of $65.00 and a low estimate of $35.00. This upward trend is evident, with the current average reflecting a 9.72% increase from the previous average price target of $42.38.

1722340829_0.png

Decoding Analyst Ratings: A Detailed Look

An...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする